Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRCQP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,790
Award facts
- Contract value 100% obligated
- $10,789.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,789.79 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30s under a firm fixed price contract structure. This non-competitive delivery order is expected to be completed by July 21, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor indicated for the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products for military healthcare systems.
This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies comprehensive medical commodities including specialty medications, brand-name and generic pharmaceuticals, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded contracts demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FRCQP?
SPE2DB25FRCQP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FRCQP worth?
The government has obligated $10,790 on SPE2DB25FRCQP.
Is contract SPE2DB25FRCQP an order under another contract?
Yes. SPE2DB25FRCQP is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCQP competed?
The extent of competition for SPE2DB25FRCQP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award